Auteurs Bost F, Rena G, Viollet B
Frontiers in endocrinology Jan 2019
Hypoxia protects against the cell death triggered by oxovanadium-galactomannan complexes in HepG2 cells.Auteurs Meyenberg Cunha-de Padua M, Noleto GR, de Oliveira Petkowicz CL, Cadena SMSC, Bost F, Pouysségur J, Mazure NM
Cellular & molecular biology letters Jan 2019
The metabolic modulator PGC-1α in cancer.Auteurs Bost F, Kaminski L
American journal of cancer research Jan 2019
Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells.Auteurs Berthe A, Zaffino M, Muller C, Foulquier F, Houdou M, Schulz C, Bost F, De Fay E, Mazerbourg S, Flament S
Breast cancer research and treatment Oct 2018
Hypoxic-induced truncation of voltage-dependent anion channel 1 is mediated by both asparagine endopeptidase and calpain 1 activities.Auteurs Pahima H, Reina S, Tadmor N, Dadon-Klein D, Shteinfer-Kuzmine A, Mazure NM, De Pinto V, Shoshan-Barmatz V
Oncotarget Fév 2018
The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.Auteurs Ambrosetti D, Dufies M, Dadone B, Durand M, Borchiellini D, Amiel J, Pouyssegur J, Rioux-Leclercq N, Pages G, Burel-Vandenbos F, Mazure NM
PloS one Jan 2018
Dysfunction in the mitochondrial Fe-S assembly machinery leads to formation of the chemoresistant truncated VDAC1 isoform without HIF-1α activation.Auteurs Ferecatu I, Canal F, Fabbri L, Mazure NM, Bouton C, Golinelli-Cohen MP
PloS one Jan 2018
The primary cilium is necessary for the differentiation and the maintenance of human adipose progenitors into myofibroblasts.Auteurs Arrighi N, Lypovetska K, Moratal C, Giorgetti-Peraldi S, Dechesne CA, Dani C, Peraldi P
Scientific reports Nov 2017
Sirtuin 7: a new marker of aggressiveness in prostate cancer.Auteurs Haider R, Massa F, Kaminski L, Clavel S, Djabari Z, Robert G, Laurent K, Michiels JF, Durand M, Ricci JE, Tanti JF, Bost F, Ambrosetti D
Oncotarget Sep 2017
The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells.Auteurs Loubiere C, Clavel S, Gilleron J, Harisseh R, Fauconnier J, Ben-Sahra I, Kaminski L, Laurent K, Herkenne S, Lacas-Gervais S, Ambrosetti D, Alcor D, Rocchi S, Cormont M, Michiels JF, Mari B, Mazure NM, Scorrano L, Lacampagne A, Gharib A, Tanti JF, Bost F
Scientific reports Juil 2017